mayo clinic glp-1 diet Healthy weight loss when GLP-1s are not an option Why do some people lose

Overview of the actions of GLP-1 in the central nervous system

The role of anti-inflammatory agents in Parkinson's disease

A CBT therapist might help you change binge behaviors by helping you think more rationally or positively about food or body image

Clinical trials and real-world use have shown that patients lost between 15-21% of their body weight while taking tirzepatide

Nonfatal myocardial infarction occurred in 2.3% of patients treated with oral semaglutide and 1.9% treated with placebo (HR 1.18, 95% CI 0.731.90), nonfatal stroke occurred in 0.8% versus 1.0% treated with placebo (HR 0.74, 95% CI 0.351.57), and death from cardiovascular causes occurred in 0.9% versus 1.9% treated with placebo (HR 0.51, 95% CI 0.310.84)

Together, we will uncover the potential of GLP-1 in managing inflammation and chronic diseases